Skip to main content
. Author manuscript; available in PMC: 2022 Sep 6.
Published in final edited form as: Am J Med Genet B Neuropsychiatr Genet. 2021 Sep 6;186(5):329–338. doi: 10.1002/ajmg.b.32872

Table 1:

SUBSTUDY Sample Size (N) (SCZ/Control) AgeSCZ Agecontrol SexSCZ (N) Sexcontrol (N)

Neanderthal DNA & Schizophrenia Diagnosis
 NIMH 1367 (537/830) 34.1±10.1 yrs 31.1±9.7 yrs 397 M, 140 F 381 M, 449 F
 Ashkenazi Jewish 3052 (1027/2025) 45.3±13.9 yrs 42.4±16.7 yrs 649 M, 378 F 1482 M, 543 F
 GAIN Schizophrenia 2550 (1173/1377) 43.8±11.3 yrs 51.1±17.0 yrs 820 M, 353 F 633 M, 744 F
 Non-GAIN Schizophrenia* 2393 (1100/1293) 43.0±12.0 yrs 49.9±15.8 yrs 766 M, 334 F 644 M, 649 F
Total 9362 (3837/5525) 42.6±12.6 yrs 44.6±17.1 yrs 2632 M/1205 F 3140 M, 2385 F

Neanderthal DNA & Schizophrenia symptoms (NIMH subsample) 49 (49/0) 29.9±9.0 yrs N/A 37 M, 12 F N/A

Neanderthal DNA & FDOPA PET (NIMH subsample) 173 (0/173) N/A 36.5±12.4 yrs N/A 86 M, 87 F
*

Age was not provided for 1.2% of the samples from the non-GAIN Schizophrenia dataset.

Abbreviations:

SCZ = Schizophrenia

FDOPA = 18F-fluorodopa

PET = positron emission tomography

Yrs = years

M = Male F = Female